Comparison of the effects of pravastatin and lovastatin on sleep disturbance in hypercholesterolemic subjects

Sleep

Volumn 22, Issue 1, 1999, Pages 117-121

  Ehrenberg, Bruce L ^a   Lamon Fava, Stefania ^b   Corbett, Kate E ^a   McNamara, Judith R ^b   Dallal, Gerard E ^c   Schaefer, Ernst J ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Hydroxy methylglutaryl coenzyme A; Hypercholesterolemia; Lovastatin; Pravastatin

Indexed keywords

MEVINOLIN; PRAVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER;

EID: 0033083183     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/22.1.117     Document Type: Article

References (16)

1. Schaefer EJ, Genest JJ, Ordovas JM, Salem DN, Wilson PWF. Familial lipoprotein disorders and premature coronary artery disease. Atherosclerosis 1994;108:S41-S54.
2. Tobert JA. The HMG-CoA reductase inhibitors. Similarities and differences. Current Patents
3. Serajuddin ATM, Ranadive SA, Mahoney EM. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. J Pharmaceut Sciences 1991;80:830-834.
4. Botti RE, Triscari J, Pan HY, Zayat J. Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin Neuropharm 1991;14:256-261.
5. Mahoney EM, Child MJ, Smith-Monroy CA. Differential transport of pravastatin and lovastatin by hepatocytes and fibroblasts. Circulation 1990;82:III-6 (abstract).
6. Vgontzas AN, Kales A, Bixler EO, Manfredi RL, Tyson KL. Effects of lovastatin and pravastatin on sleep efficiency and sleep stages. Clin Pharmacol Ther 1991;50:730-737.
7. Roth T, Richardson GR, Sullivan JP, Lee RM, Merlotti L, Roehrs T. Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance. Clin Cardiol 1992;15:426-432.
8. Johnson LC, Church MW, Seales DM, Rossiter VS. Auditory arousal threshold of good sleepers and poor sleepers with and without flurazepam. Sleep 1979;1:250270.
9. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chem 1982;28:1379-1388.
10. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
12. Schaefer EJ. HMG-CoA reductase inhibitors for hypercholesterolemia. N Enlg J Med (letter) 1988;319:1222.
13. Barth JD, Kruisbrink OAE, van Dijk AL. Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia. BMJ (letter) 1990;301:669.
14. Black DM, Lamkin G, Olivera EH, Laskarzewski PM, Stein EA. Sleep disturbance and HMG CoA reductase inhibitors. JAMA (letter) 1990;264:1105.
15. Mantell G, Burke MT, Staggers J. Extended clinical safety profile of lovastatin. Am J Cardiol 1990;66:11B-15B.
16. Sheperd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesteroemia. N Engl J Med 1995;333:1301-1307.